Nitric oxide and reactive oxygen species in limb vascular function: What is the effect of physical activity?

Free Radical Research

Volumn 48, Issue 1, 2014, Pages 71-83

  Gliemann, L ^a   Nyberg, M ^a   Hellsten, Y ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Aging; Cardiovascular; Hypertension; Nitric oxide synthase; Oxidative stress; Peripheral artery disease

Indexed keywords

ANGIOTENSIN II; ANTIOXIDANT; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE A2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; XANTHINE OXIDASE;

AGING; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; BIOAVAILABILITY; BLOOD VESSEL FUNCTION; CARDIOVASCULAR FUNCTION; CELL DAMAGE; CELL FUNCTION; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; EXERCISE; HUMAN; INTERMITTENT CLAUDICATION; LIMB BLOOD FLOW; LIMB BLOOD VESSEL; MITOCHONDRION; MUSCLE BLOOD FLOW; MUSCLE CONTRACTION; MYALGIA; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SHEAR STRESS; SKELETAL MUSCLE; VASCULITIS; VASOCONSTRICTION;

ANIMALS; ARM; ENDOTHELIUM, VASCULAR; EXERCISE; EXTREMITIES; HUMANS; HYPERTENSION; LEG; NITRIC OXIDE; OXIDATIVE STRESS; PERIPHERAL ARTERIAL DISEASE; PHYSICAL CONDITIONING, ANIMAL; REACTIVE OXYGEN SPECIES;

EID: 84890014547     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2013.835045     Document Type: Review

References (155)

1. Jackson MJ, Pye D, Palomero J. The production of reactive oxygen and nitrogen species by skeletal muscle. J Appl Physiol 2007; 102: 1664-1670.
2. Lindsay TF, Liauw S, Romaschin AD, Walker PM. The effect of ischemia/reperfusion on adenine nucleotide metabolism and xanthine oxidase production in skeletal muscle. J Vasc Surg 1990; 12: 8-15.
3. Vi n a J, Gimeno A, Sastre J, Desco C, Asensi M, Pallard o FV, et al. Mechanism of free radical production in exhaustive exercise in humans and rats; role of xanthine oxidase and protection by allopurinol. IUBMB Life 2000; 49: 539-544.
4. Wolff DJ, Mialkowski K, Richardson CF, Wilson SR. C60-Fullerene monomalonate adducts selectively inactivate neuronal nitric oxide synthase by uncoupling the formation of reactive oxygen intermediates from nitric oxide production. Biochemistry 2001; 40: 37-45.
5. List BM, Kl o sch B, V o lker C, Gorren AC, Sessa WC, Werner ER, et al. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: Tetrahydrobiopterin binding kinetics and role of haem in dimerization. Biochem J 1997; 323: 159-165.
6. F o rstermann U, Sessa WC. Nitric oxide synthases: Regulation and function. Eur Heart J 2012; 33: 829-837.
7. Takac I, Schr o der K, Brandes RP. The Nox family of NADPH oxidases: Friend or foe of the vascular system? Curr Hypertens Rep 2012; 14: 70-78.
8. Hellsten-Westing Y. Immunohistochemical localization of xanthine oxidase in human cardiac and skeletal muscle. Histochemistry 1993; 100: 215-222.
9. Corte Della E, Stirpe F. Regulation of xanthine oxidase in rat liver: Modifi cations of the enzyme activity of rat liver supernatant on storage at 20 degrees. Biochem J 1968; 108: 349-351.
10. Corte Della E, Stirpe F. The regulation of xanthine oxidase. Inhibition by reduced nicotinamide-Adenine dinucleotide of rat liver xanthine oxidase type D and of chick liver xanthine dehydrogenase. Biochem J 1970; 117: 97-100.
11. Wilkins EG, Rees RS, Smith D, Cashmer B, Punch J, Till GO, Smith DJ Jr. Identifi cation of xanthine oxidase activity following reperfusion in human tissue. Ann Plast Surg1993; 31: 60-65.
12. Korthuis RJ, Granger DN, Townsley MI, Taylor AE. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res 1985; 57: 599-609.
13. Smith JK, Carden DL, Korthuis RJ. Role of xanthine oxidase in postischemic microvascular injury in skeletal muscle. Am J Physiol 1989; 257: H1782-H1789.
14. Gomez-Cabrera MC, Borras C, Pallardo FV, Sastre J, Ji LL, Vi n a J. Decreasing xanthine oxidase-mediated oxidative stress prevents useful cellular adaptations to exercise in rats. J Physiol 2005; 567: 113-120.
15. Boveris A, Oshino N, Chance B. The cellular production of hydrogen peroxide. Biochem J 1972; 128: 617-630.
16. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973; 134: 707-716.
17. St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 2002; 277: 44784-44790.
18. McArdle F, Pattwell DM, Vasilaki A, McArdle A, Jackson MJ. Intracellular generation of reactive oxygen species by contracting skeletal muscle cells. Free Radic Biol Med 2005; 39: 651-657.
19. Brown GC, Borutaite V. There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells. Mitochondrion 2012; 12: 1-4.
20. Davies KJ, Quintanilha AT, Brooks GA, Packer L. Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 1982; 107: 1198-1205.
21. Hellsten Y, Nielsen JJ, Lykkesfeldt J, Bruhn M, Silveira L, Pilegaard H, Bangsbo J. Antioxidant supplementation enhances the exercise-induced increase in mitochondrial uncoupling protein 3 and endothelial nitric oxide synthase mRNA content in human skeletal muscle. Free Radic Biol Med 2007; 43: 353-361.
22. Silveira LR, Pereira-Da-Silva L, Juel C, Hellsten Y. Formation of hydrogen peroxide and nitric oxide in rat skeletal muscle cells during contractions. Free Radic Biol Med 2003; 35: 455-464.
23. Aldred S. Oxidative and nitrative changes seen in lipoproteins following exercise. Atherosclerosis 2007; 192: 1-8.
24. Lamontagne D, Pohl U, Busse R. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 1992; 70: 123-130.
25. Koller A, Sun D, Huang A, Kaley G. Corelease of nitric oxide and prostaglandins mediates fl ow-dependent dilation of rat gracilis muscle arterioles. Am J Physiol 1994; 267: H326-H332.
26. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: Role of a superoxide-producing NADH oxidase. Circ Res 1998; 82: 1094-1101.
27. White SJ, Hayes EM, Lehoux S, Jeremy JY, Horrevoets AJG, Newby AC. Characterization of the differential response of endothelial cells exposed to normal and elevated laminar shear stress. J Cell Physiol 2011; 226: 2841-2848.
28. Hwang J, Ing MH, Salazar A, Lass e gue B, Griendling K, Navab M, et al. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: Implication for native LDL oxidation. Circ Res 2003; 93: 1225-1232.
29. Powers SK, Duarte J, Kavazis AN, Talbert EE. Reactive oxygen species are signalling molecules for skeletal muscle adaptation. Exp Physiol 2010; 95: 1-9.
30. Westerblad H, Allen DG. Emerging roles of ROS/RNS in muscle function and fatigue. Antioxid Redox Signal 2011; 15: 2487-2499.
31. Garry A, Edwards DH, Fallis IF, Jenkins RL, Griffith TM. Ascorbic acid and tetrahydrobiopterin potentiate the EDHF phenomenon by generating hydrogen peroxide. Cardiovasc Res 2009; 84: 218-226.
32. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 2002; 106: 2800-2805.
33. Muller MD, Drew RC, Blaha CA, Mast JL, Cui J, Reed AB, Sinoway LI. Oxidative stress contributes to the augmented exercise pressor refl ex in peripheral arterial disease patients. J Physiol 2012; 590: 6237-6246.
34. Hajjar DP, Gotto AM. Biological relevance of infl ammation and oxidative stress in the pathogenesis of arterial diseases. Am J Pathol 2013; 182: 1474-1481.
35. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G, Shah AM. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 2003; 41: 2164-2171.
36. Xie W, Parker JL, Heaps CL. Effect of exercise training on nitric oxide and superoxide/H O signaling pathways in collateral-dependent porcine coronary arterioles. J Appl Physiol 2012; 112: 1546-1555.
37. Gliemann L, Schmidt JF, Olesen J, Biens o RS, Peronard SL, Grandjean SU, et al. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol 2013. Doi:10.1113/jphysiol.2013. 258061
38. Hellsten Y, Apple FS, Sj o din B. Effect of sprint cycle training on activities of antioxidant enzymes in human skeletal muscle. J Appl Physiol 1996; 81: 1484-1487.
39. Aslan R, Ş ekero ǧ lu MR, Tarak c io ǧ lu M, Bayiro ǧ lu F, MERAL İ. Effect of acute and regular exercise on antioxidative enzymes, tissue damage markers and membran lipid peroxidation of erythrocytes in sedentary students. Tr J Med Sci 1998; 21: 19-25.
40. Tessier F, Hida H, Favier A, Marconnet P. Muscle GSH-Px activity after prolonged exercise, training, and selenium supplementation. Biol Trace Elem Res 1995; 47: 279-285.
41. Tiidus PM, Pushkarenko J, Houston ME. Lack of antioxidant adaptation to short-Term aerobic training in human muscle. Am J Physiol 1996; 271: R832-R836.
42. Devries MC, Hamadeh MJ, Glover AW, Raha S, Samjoo IA, Tarnopolsky MA. Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on infl ammation in lean and obese women. Free Radic Biol Med 2008; 45: 503-511.
43. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, et al. Antioxidative effects of exercise training in patients with chronic heart failure: Increase in radical scavenger enzyme activity in skeletal muscle. Circulation 2005; 111: 1763-1770.
44. Teixeira V, Valente H, Casal S, Pereira L, Marques F, Moreira P. Antioxidant status, oxidative stress, and damage in elite kayakers after 1 year of training and competition in 2 seasons. Appl Physiol Nutr Metab 2009; 34: 716-724.
45. Garc i a-L o pez D, H a kkinen K, Cuevas MJ, Lima E, Kauhanen A, Mattila M, et al. Effects of strength and endurance training on antioxidant enzyme gene expression and activity in middle-Aged men. Scand J Med Sci Sports 2007; 17: 595-604.
46. Elosua R, Molina L, Fito M, Arquer A, Sanchez-Quesada JL, Covas MI, et al. Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis 2003; 167: 327-334.
47. Zago AS, Park JY, Fenty-Stewart N, Silveira LR, Kokubun E, Brown MD. Effects of aerobic exercise on the blood pressure, oxidative stress and eNOS gene polymorphism in prehypertensive older people. Eur J Appl Physiol 2010; 110: 825-832.
48. Fatouros IG, Jamurtas AZ, Villiotou V, Pouliopoulou S, Fotinakis P, Taxildaris K, Deliconstantinos G. Oxidative stress responses in older men during endurance training and detraining. Med Sci Sports Exerc 2004; 36: 2065-2072.
49. Ohno H, Yahata T, Sato Y, Yamamura K, Taniguchi N. Physical training and fasting erythrocyte activities of free radical scavenging enzyme systems in sedentary men. Eur J Appl Physiol Occup Physiol 1988; 57: 173-176.
50. Miyazaki H, Oh-ishi S, Ookawara T, Kizaki T, Toshinai K, Ha S, et al. Strenuous endurance training in humans reduces oxidative stress following exhausting exercise. Eur J Appl Physiol 2001; 84: 1-6.
51. Robertson JD, Maughan RJ, Duthie GG, Morrice PC. Increased blood antioxidant systems of runners in response to training load. Clin Sci (Lond) 1991; 80: 611-618.
52. Rousseau AS, Margaritis I, Arnaud J, Faure H, Roussel AM. Physical activity alters antioxidant status in exercising elderly subjects. J Nutr Biochem 2006; 17: 463-470.
53. Knez WL, Jenkins DG, Coombes JS. Oxidative stress in half and full Ironman triathletes. Med Sci Sports Exerc 2007; 39: 283-288.
54. Brites FD, Evelson PA, Christiansen MG, Nicol MF, Bas i lico MJ, Wikinski RW, Llesuy SF. Soccer players under regular training show oxidative stress but an improved plasma antioxidant status. Clin Sci (Lond) 1999; 96: 381-385.
55. Evelson P, Gambino G, Travacio M, Jaita G, Verona J, Maroncelli C, et al. Higher antioxidant defences in plasma and low density lipoproteins from rugby players. Eur J Clin Invest 2002; 32: 818-825.
56. Cazzola R, Russo-Volpe S, Cervato G, Cestaro B. Biochemical assessments of oxidative stress, erythrocyte membrane fl uidity and antioxidant status in professional soccer players and sedentary controls. Eur J Clin Invest 2003; 33: 924-930.
57. Frandsen U, LopezFigueroa M, Hellsten Y. Localization of nitric oxide synthase in human skeletal muscle. Biochem Biophys Res Commun 1996; 227: 88-93.
58. Hellsten Y, Nyberg M, Mortensen SP. Contribution of intravascular versus interstitial purines and nitric oxide in the regulation of exercise hyperaemia in humans. J Physiol 2012; 590: 5015-5023.
59. Bloodsworth A, O'Donnell VB, Freeman BA. Nitric oxide regulation of free radical- And enzyme-mediated lipid and lipoprotein oxidation. Arterioscler Thromb Vasc Biol 2000; 20: 1707-1715.
60. Hellsten Y, Nyberg M, Jensen LG, Mortensen SP. Vasodilator interactions in skeletal muscle blood fl ow regulation. J Physiol 2012; 590: 6297-6305.
61. R a degran G, Saltin B. Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. Am J Physiol 1999; 276: H1951-H1960.
62. Heinonen I, Bengt S, Jukka K, Sipil a HT, Vesa O, Pirjo N, et al. Skeletal muscle blood fl ow and oxygen uptake at rest and during exercise in humans: A pet study with nitric oxide and cyclooxygenase inhibition. Am J Physiol Heart Circ Physiol 2011; 300: 1510-1517.
63. Vallance P, Collier J, Moncada S. Effects of endotheliumderived nitric oxide on peripheral arteriolar tone in man. Lancet; 1989; 334: 997-1000.
64. Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA. Contribution of endotheliumderived nitric oxide to exercise-induced vasodilation. Circulation 1994; 90: 2853-2858.
65. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993; 87: 1475-1481.
66. Schrage WG, Wilkins BW, Johnson CP, Eisenach JH, Limberg JK, Dietz NM, et al. Roles of nitric oxide synthase and cyclooxygenase in leg vasodilation and oxygen consumption during prolonged low-intensity exercise in untrained humans. J Appl Physiol 2010; 109: 768-777.
67. Bradley SJ, Kingwell BA, McConell GK. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood fl ow during dynamic exercise in humans. Diabetes 1999; 48: 1815-1821.
68. Kingwell BA, Formosa M, Muhlmann M, Bradley SJ, McConell GK. Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects. Diabetes 2002; 51: 2572-2580.
69. Schrage WG, Eisenach JH, Joyner MJ. Ageing reduces nitricoxide-And prostaglandin-mediated vasodilatation in exercising humans. J Physiol 2007; 579: 227-236.
70. Schrage WG. Local inhibition of nitric oxide and prostaglandins independently reduces forearm exercise hyperaemia in humans. J Physiol 2004; 557: 599-611.
71. Mortensen SP, Gonzalez-Alonso J, Damsgaard R, Saltin B, Hellsten Y. Inhibition of nitric oxide and prostaglandins, but not endothelial-derived hyperpolarizing factors, reduces blood fl ow and aerobic energy turnover in the exercising human leg. J Physiol 2007; 581: 853-861.
72. Hillig T, Krustrup P, Fleming I, Osada T, Saltin B, Hellsten Y. Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood fl ow and oxygen uptake in humans. J Physiol 2003; 546: 307-314.
73. Miller VM, Vanhoutte PM. Enhanced release of endothelium-derived factor(s) by chronic increases in blood fl ow. Am J Physiol 1988; 255: H446-H451.
74. Harris MB, Mitchell BM, Sood SG, Webb RC, Venema RC. Increased nitric oxide synthase activity and Hsp90 association in skeletal muscle following chronic exercise. Eur J Appl Physiol 2008; 104: 795-802.
75. Nyberg M, Jensen LG, Thaning P, Hellsten Y, Mortensen SP. Role of nitric oxide and prostanoids in the regulation of leg blood fl ow and blood pressure in humans with essential hypertension: Effect of high-intensity aerobic training. J Physiol 2012; 590: 1481-1494.
76. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994; 74: 349-353.
77. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992; 90: 2092-2096.
78. Mortensen SP, Nyberg M, Thaning P, Saltin B, Hellsten Y. Adenosine contributes to blood fl ow regulation in the exercising human leg by increasing prostaglandin and nitric oxide formation. Hypertension 2009; 53: 993-999.
79. Nyberg M, Mortensen SP, Thaning P, Saltin B, Hellsten Y. Interstitial and plasma adenosine stimulate nitric oxide and prostacyclin formation in human skeletal muscle. Hypertension 2010; 56: 1102-1108.
80. Mortensen SP, Gonz a lez-Alonso J, Bune LT, Saltin B, Pilegaard H, Hellsten Y. ATP-induced vasodilation and purinergic receptors in the human leg: Roles of nitric oxide, prostaglandins, and adenosine. Am J Physiol Regul Integr Comp Physiol 2009; 296: R1140-R1148.
81. Eskurza I, Myerburgh LA, Kahn ZD, Seals DR. Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults. J Physiol 2005; 568: 1057-1065.
82. Mizutani M, Hashimoto R, Ohta T, Nakazawa K, Nagatsu T. The effect of exercise on plasma biopterin levels. Neuropsychobiology 1994; 29: 53-56.
83. Nyberg M, Blackwell JR, Damsgaard R, Jones AM, Hellsten Y, Mortensen SP. Lifelong physical activity prevents an agerelated reduction in arterial and skeletal muscle nitric oxide bioavailability in humans. J Physiol 2012; 590: 5361-5370.
84. McConell GK, Bradley SJ, Stephens TJ, Canny BJ, Kingwell BA, Lee-Young RS. Skeletal muscle nNOS mu protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol 2007; 293: R821-R828.
85. Cooke JP. Asymmetrical dimethylarginine: The Uber marker? Circulation 2004; 109: 1813-1818.
86. Abbasi F, Asagmi T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, et al. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol 2001; 88: 1201-1203.
87. Perticone F, Sciacqua A, Maio R, Perticone M, Leone GG, Bruni R, et al. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension. Int J Cardiol 2010; 142: 236-241.
88. B o ger RH, Endres HG, Schwedhelm E, Darius H, Atzler D, L uneburg N, et al. Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease. J Intern Med 2011; 269: 349-361.
89. Reusch JEB, Bridenstine M, Regensteiner JG. Type 2 diabetes mellitus and exercise impairment. Rev Endocr Metab Disord 2013; 14: 77-86.
90. Hiatt WR. Carnitine and peripheral arterial disease. Ann N Y Acad Sci 2004; 1033: 92-98.
91. Hanssen H, Nickel T, Drexel V, Hertel G, Emslander I, Sisic Z, et al. Exercise-induced alterations of retinal vessel diameters and cardiovascular risk reduction in obesity. Atherosclerosis 2011; 216: 433-439.
92. Richter B, Niessner A, Penka M, Grdi ć M, Steiner S, Strasser B, et al. Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events. T hromb Haemost 2 005; 9 4: 1 306-1 311.
93. Schlager O, Giurgea A, Schuhfried O, Seidinger D, Hammer A, Gr oger M, et al. Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: A randomized controlled trial. Atherosclerosis 2011; 217: 240-248.
94. Mittermayer F, Pleiner J, Krzyzanowska K, Wiesinger GF, Francesconi M, Wolzt M. Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus. Wien Klin Wochenschr 2005; 117: 816-820.
95. Sydow K, Schwedhelm E, Arakawa N, Bode-B o ger SM, Tsikas D, Hornig B, et al. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e) inemia: Effects of L-Arginine and B vitamins. Cardiovasc Res 2003; 57: 244-252.
96. Mohan S, Fung HL. Mechanism of cellular oxidation stress induced by asymmetric dimethylarginine. Int J Mol Sci 2012; 13: 7521-7531.
97. Sydow K, M u nzel T. ADMA and oxidative stress. Atheroscler Suppl 2003; 4: 41-51.
98. Eskurza I, Monahan KD, Robinson JA, Seals DR. Effect of acute and chronic ascorbic acid on fl ow-mediated dilatation with sedentary and physically active human ageing. J Physiol 2004; 556: 315-324.
99. Taddei S, Galetta F, Virdis A, Ghiadoni L, Salvetti G, Franzoni F, et al. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation 2000; 101: 2896-2901.
100. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 2001; 38: 274-279.
101. Lauer T, Heiss C, Balzer J, Kehmeier E, Mangold S, Leyendecker T, et al. Age-dependent endothelial dysfunction is associated with failure to increase plasma nitrite in response to exercise. Basic Res Cardiol 2008; 103: 291-297.
102. Crecelius AR, Kirby BS, Voyles WF, Dinenno FA. Nitric oxide, but not vasodilating prostaglandins, contributes to the improvement of exercise hyperemia via ascorbic acid in healthy older adults. Am J Physiol Heart Circ Physiol 2010; 299: H1633-H1641.
103. Kirby BS, Voyles WF, Simpson CB, Carlson RE, Schrage WG, Dinenno FA. Endothelium-dependent vasodilatation and exercise hyperaemia in ageing humans: Impact of acute ascorbic acid administration. J Physiol 2009; 587: 1989-2003.
104. Frandsen U, Hoff ner L, Betak A, Saltin B, Bangsbo J, Hellsten Y. Endurance training does not alter the level of neuronal nitric oxide synthase in human skeletal muscle. J Appl Physiol 2000; 89: 1033-1038.
105. H o ier B, Nordsborg N, Andersen S, Jensen L, Nybo L, Bangsbo J, Hellsten Y. Pro- And anti-Angiogenic factors in human skeletal muscle in response to acute exercise and training. J Physiol 2011; 590: 595-606.
106. Soucy KG, Ryoo S, Benjo A, Lim HK, Gupta G, Sohi JS, et al. Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiff ness. J Appl Physiol. 2 006; 1 01: 1 751-1 759.
107. Trott DW, Gunduz F, Laughlin MH, Woodman CR. Exercise training reverses age-related decrements in endothelium-dependent dilation in skeletal muscle feed arteries. J Appl Physiol 2009; 106: 1925-1934.
108. Sindler AL, Delp MD, Reyes R, Wu G, Muller-Delp JM. Effects of ageing and exercise training on eNOS uncoupling in skeletal muscle resistance arterioles. J Physiol 2009; 587: 3885-3897.
109. Ortenblad N, Madsen K, Djurhuus MS. Antioxidant status and lipid peroxidation after short-Term maximal exercise in trained and untrained humans. Am J Physiol 1997; 272: R1258-R1263.
110. Ghiadoni L, Taddei S, Virdis A. Hypertension and endothelial dysfunction: Therapeutic approach. Curr Vasc Pharmacol 2012; 10: 42-60. 82 L. Gliemann et al.
111. Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 2011; 10: 453-471.
112. Fanelli C, Zatz R. Linking oxidative stress, the renin-Angiotensin system, and hypertension. Hypertension. 2011; 57: 373-374.
113. Zhao W, Swanson SA, Ye J, Li X, Shelton JM, Zhang W, Thomas GD. Reactive oxygen species impair sympathetic vasoregulation in skeletal muscle in angiotensin II-dependent hypertension. Hypertension 2006; 48: 637-643.
114. Remensnyder JP, Mitchell JH, Sarnoff SJ. Functional sympatholysis during muscular activity. Observations on infl uence of carotid sinus on oxygen uptake. Circ Res 1962; 11: 370-380.
115. Saltin B, Mortensen SP. Inefficient functional sympatholysis is an overlooked cause of malperfusion in contracting skeletal muscle. J Physiol 2012; 590: 6269-6275.
116. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998; 97: 2222-2229.
117. Rowell LB. Human cardiovascular control. New York: Oxford University Press; 1993.
118. Arvola P, Wu X, K a h o nen M, M a kynen H, Riutta A, Mucha I, et al. Exercise enhances vasorelaxation in experimental obesity associated hypertension. Cardiovasc Res 1999; 43: 992-1002.
119. Chen Y, Collins HL, DiCarlo SE. Daily exercise enhances acetylcholine-induced dilation in mesenteric and hindlimb vasculature of hypertensive rats. Clin Exp Hypertens 1999; 21: 353-376.
120. Roque FR, Briones AM, Garc i a-Redondo AB, Gal a n M, Mart i nez-Revelles S, Avenda n o MS, et al. Aerobic exercise reduces oxidative stress and improves vascular changes of small mesenteric and coronary arteries in hypertension. Br J Pharmacol 2013; 168: 686-703.
121. Higashi Y, Sasaki S, Kurisu S, Yoshimizu A, Sasaki N, Matsuura H, et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: Role of endothelium-derived nitric oxide. Circulation 1999; 100: 1194-1202.
122. Higashi Y, Sasaki S, Sasaki N, Nakagawa K, Ueda T, Yoshimizu A, et al. Daily aerobic exercise improves reactive hyperemia in patients with essential hypertension. Hypertension 1999; 33: 591-597.
123. Rush JWE, Turk JR, Laughlin MH. Exercise training regulates SOD-1 and oxidative stress in porcine aortic endothelium. Am J Physiol Heart Circ Physiol 2003; 284: H1378-H1387.
124. Agarwal D, Haque M, Sriramula S, Mariappan N, Pariaut R, Francis J. Role of proinfl ammatory cytokines and redox homeostasis in exercise-induced delayed progression of hypertension in spontaneously hypertensive rats. Hypertension 2009; 54: 1393-400.
125. Kimura H, Kon N, Furukawa S, Mukaida M, Yamakura F, Matsumoto K, et al. Effect of endurance exercise training on oxidative stress in spontaneously hypertensive rats (SHR) after emergence of hypertension. Clin Exp Hypertens 2010; 32: 407-415.
126. Zalba G, Beaumont FJ, San Jos e G, Fortu n o A, Fortu n o MA, Etayo JC, D i ez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055-1061.
127. Saltin B, Nazar K, Costill DL, Stein E, Jansson E, Ess e n B, et al. The nature of the training response; peripheral and central adaptations of one-legged exercise. Acta Physiol Scand 1976; 96: 289-305.
128. Kalliokoski KK, Oikonen V, Takala TO, Sipil a H, Knuuti J, Nuutila P heterogeneity in exercising muscle in endurance-Trained men. Am J Physiol Endocrinol Metab 2001; 280: E1015-E1021.
129. Proctor DN, Miller JD, Dietz NM, Minson CT, Joyner MJ. Reduced submaximal leg blood fl ow after high-intensity aerobic training. J Appl Physiol 2001; 91: 2619-2627.
130. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997; 29: 274-279.
131. Hansen AH, Nyberg M, Bangsbo J, Saltin B, Hellsten Y. Exercise training alters the balance between vasoactive compounds in skeletal muscle of individuals with essential hypertension. Hypertension 2011; 58: 943-949.
132. Heerkens EHJ, Izzard AS, Heagerty AM. Integrins, vascular remodeling, and hypertension. Hypertension 2007; 49: 1-4.
133. Laterza MC, de Matos LD, Trombetta IC, Braga AM, Roveda F, Alves MJ, et al. Exercise training restores barorefl ex sensitivity in never-Treated hypertensive patients. Hypertension 2007; 49: 1298-1306.
134. Liao JK, Bettmann MA, Sandor T, Tucker JI, Coleman SM, Creager MA. Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. Circ Res 1991; 68: 1027-1034.
135. Yataco AR, Corretti MC, Gardner AW, Womack CJ, Katzel LI. Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am J Cardiol 1999; 83: 754-758.
136. Liao JC, Hein TW, Vaughn MW, Huang KT, Kuo L. Intravascular fl ow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci USA 1999; 96: 8757-8761.
137. Mortensen SP, Askew CD, Walker M, Nyberg M, Hellsten Y. The hyperaemic response to passive leg movement is dependent on nitric oxide; a new tool to evaluate endothelial nitric oxide function. J Physiol 2012; 590: 4391-4400.
138. Li H, F o rstermann U. Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease. Curr Opin Pharmacol 2013; 13: 161-167.
139. Allen JD, Giordano T, Kevil CG. Nitrite and nitric oxide metabolism in peripheral artery disease. Nitric Oxide 2012; 26: 217-222.
140. Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: A clinicobiochemical perspective. Angiology 2007; 58: 513-522.
141. Ribeiro F, Alves AJ, Duarte JA, Oliveira J. Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall infl ammation? Int J Cardiol 2010; 141: 214-221.
142. Burchardt P, Zurawski J, Zuchowski B, Kubacki T, Murawa D, Wiktorowicz K, Wysocki H. Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-Associated phospholipase A2 and carboxyl ester lipase lipases in atherosclerotic plaque formation. A rch Med Sci 2 013; 9: 1 51-1 58.
143. Sorescu D, Weiss D, Lass e gue B, Clempus RE, Sz o cs K, Sorescu GP, et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002; 105: 1429-1435.
144. Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, Przybylowski P, et al. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 333-339.
145. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 2011; 31: 969-979.
146. Pashkow FJ. Oxidative stress and infl ammation in heart disease: Do antioxidants have a role in treatment and/or prevention? Int J Infl am 2011; 2011: 514623.
147. Kalanuria AA, Nyquist P, Ling G. The prevention and regression of atherosclerotic plaques: Emerging treatments. Vasc Health Risk Manag 2012; 8: 549-561.
148. Osinbowale OO, Milani RV. Benefi ts of exercise therapy in peripheral a
149. Parmenter BJ, Raymond J, Fiatarone Singh MA. The effect of exercise on fi tness and performance-based tests of function in intermittent claudication: A systematic review. Sports Med 2013; 43: 513-524.
150. Duscha BD, Robbins JL, Jones WS, Kraus WE, Lye RJ, Sanders JM, et al. Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients. Arterioscler Thromb Vasc Biol 2011; 31: 2742-2748.
151. Thijssen DHJ, Cable NT, Green DJ. Impact of exercise training on arterial wall thickness in humans. Clin Sci 2012; 122: 311-322.
152. Thijssen DHJ, Dawson EA, Tinken TM, Cable NT, Green DJ. Retrograde fl ow and shear rate acutely impair endothelial function in humans. Hypertension 2009; 53: 986-992.
153. Rush JWE, Aultman CD. Vascular biology of angiotensin and the impact of physical activity. Appl Physiol Nutr Metab 2008; 33: 162-172.
154. Szostak J, Laurant P. The forgotten face of regular physical exercise: A " natural" anti-Atherogenic activity. Clin Sci 2011; 121: 91-106.
155. Godbole AS, Lu X, Guo X, Kassab GS. NADPH oxidase has a directional response to shear stress. Am J Physiol Heart Circ Physiol 2009; 296: H152-H158.